跳至主要内容
临床试验/ACTRN12613000317796
ACTRN12613000317796招募中1 期

Feasibility Study to assess the performance of IntellaTip MiFi™ XP Temperature Ablation Catheter System for the treatment of Subjects with Sustained or Recurrent Type I Atrial Flutter

Boston Scientific Corporation0 个研究点目标入组 20 人开始时间: 2013年3月21日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • * At least one (1) documented episode of type I atrial flutter preceding enrollment documented by 12-lead ECG, Holter monitor, rhythm strip, or trans telephonic monitor
  • * Subjects are clinically indicated for standard of care catheter ablation for type I atrial flutter
  • * Age 18 or above, or of legal age to give informed consent specific to state and national law
  • * Subjects or their legal representative are competent and willing to provide written informed consent to participate in the study and agree to (and are able to) comply with follow-up visits and evaluation

排除标准

  • * Any cardiac ablation within 90 days prior to enrollment
  • * Previous CTI ablation
  • * Cardiac surgery within 90 days prior to enrollment
  • * Myocardial infarction (MI) or cardiac revascularization (percutaneous coronary intervention) within 60 days prior to enrollment
  • * Current unstable angina
  • * Documented atrial or ventricular tumors, clots, thrombus, Deep Vein Thrombus (DVT)or have a known clotting disorder within 90 days prior to enrollment
  • * Implantation of permanent leads of an implantable device in or through the right atrium within 30 days prior to enrollment.

研究者

相似试验

Feasibility Study to assess the performance of... | 临床试验